According to Dynavax Technologies 's latest financial reports the company's total assets are $0.99 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.99 B | 1.14% |
2022-12-31 | $0.98 B | -5.14% |
2021-12-31 | $1.03 B | 194.18% |
2020-12-31 | $0.35 B | 26.59% |
2019-12-31 | $0.27 B | 32.33% |
2018-12-31 | $0.21 B | -3.61% |
2017-12-31 | $0.21 B | 99.48% |
2016-12-31 | $0.10 B | -49.37% |
2015-12-31 | $0.21 B | 56.65% |
2014-12-31 | $0.13 B | -32.42% |
2013-12-31 | $0.20 B | 46.42% |
2012-12-31 | $0.13 B | 4.21% |
2011-12-31 | $0.13 B | 59.17% |
2010-12-31 | $84.24 M | 66.93% |
2009-12-31 | $50.47 M | -44.31% |
2008-12-31 | $90.62 M | -24.76% |
2007-12-31 | $0.12 B | 17.07% |
2006-12-31 | $0.10 B | 28.46% |
2005-12-31 | $80.09 M | 8.75% |
2004-12-31 | $73.64 M | 133.17% |
2003-12-31 | $31.58 M | 0.34% |
2002-12-31 | $31.47 M | 108.23% |
2001-12-31 | $15.11 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 22,616.07% | ๐บ๐ธ USA |
Amgen AMGN | $97.15 B | 9,643.70% | ๐บ๐ธ USA |
Biogen BIIB | $26.84 B | 2,592.30% | ๐บ๐ธ USA |
Gilead Sciences GILD | $62.12 B | 6,130.59% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 10,598.57% | ๐บ๐ธ USA |
AstraZeneca AZN | $101.11 B | 10,041.35% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $75.11 B | 7,433.22% | ๐ฌ๐ง UK |
Agenus
AGEN | $0.31 B | -68.52% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $43.47 B | 4,260.56% | ๐ฎ๐ฑ Israel |